Interferon may be tool to guide glucocorticoid dosage in SLE

Australian researchers have generated a five-gene molecular signature for glucocorticoid exposure in SLE. The study, published in The Lancet Rheumatology, aimed to find a useful tool for glucocorticoid dose titration and monitoring in clinical practice. While the study found a significant association of the five-gene signature with increasing glucocorticoid dose, there was high interpatient variation ...

Already a member?

Login to keep reading.

© 2021 the limbic